Pseudo-colouring an ECG enables lay people to detect QT-interval prolongation regardless of heart rate.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 27 01 2020
accepted: 04 08 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 21 10 2020
Statut: epublish

Résumé

Drug-induced long QT syndrome (diLQTS), characterized by a prolongation of the QT-interval on the electrocardiogram (ECG), is a serious adverse drug reaction that can cause the life-threatening arrhythmia Torsade de Points (TdP). Self-monitoring for diLQTS could therefore save lives, but detecting it on the ECG is difficult, particularly at high and low heart rates. In this paper, we evaluate whether using a pseudo-colouring visualisation technique and changing the coordinate system (Cartesian vs. Polar) can support lay people in identifying QT-prolongation at varying heart rates. Four visualisation techniques were evaluated using a counterbalanced repeated measures design including Cartesian no-colouring, Cartesian pseudo-colouring, Polar no-colouring and Polar pseudo-colouring. We used a multi-reader, multi-case (MRMC) receiver operating characteristic (ROC) study design within a psychophysical paradigm, along with eye-tracking technology. Forty-three lay participants read forty ECGs (TdP risk n = 20, no risk n = 20), classifying each QT-interval as normal/abnormal, and rating their confidence on a 6-point scale. The results show that introducing pseudo-colouring to the ECG significantly increased accurate detection of QT-interval prolongation regardless of heart rate, T-wave morphology and coordinate system. Pseudo-colour also helped to reduce reaction times and increased satisfaction when reading the ECGs. Eye movement analysis indicated that pseudo-colour helped to focus visual attention on the areas of the ECG crucial to detecting QT-prolongation. The study indicates that pseudo-colouring enables lay people to visually identify drug-induced QT-prolongation regardless of heart rate, with implications for the more rapid identification and management of diLQTS.

Identifiants

pubmed: 32853262
doi: 10.1371/journal.pone.0237854
pii: PONE-D-20-02458
pmc: PMC7451551
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0237854

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):2-4
pubmed: 23424219
Circulation. 2000 Jun 13;101(23):E215-20
pubmed: 10851218
QJM. 2007 Oct;100(10):609-15
pubmed: 17881416
Heart Rhythm. 2008 Jul;5(7):1015-8
pubmed: 18598957
Med Res Rev. 2005 Mar;25(2):133-66
pubmed: 15389727
Am Heart J. 2009 May;157(5):827-36, 836.e1
pubmed: 19376308
Br J Clin Pharmacol. 2010 Dec;70(6):881-5
pubmed: 21175443
Curr Opin Pediatr. 2014 Dec;26(6):727-33
pubmed: 25313972
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):76-83
pubmed: 23275261
J Am Coll Cardiol. 2009 Mar 17;53(11):982-91
pubmed: 19281931
J Clin Invest. 2005 Aug;115(8):2018-24
pubmed: 16075042
J Am Coll Cardiol. 2009 Jul 7;54(2):143-9
pubmed: 19573731
Sports Health. 2016 Nov/Dec;8(6):527-535
pubmed: 27480102
Br J Clin Pharmacol. 2003 Jun;55(6):511-7
pubmed: 12814443
J Electrocardiol. 2004;37 Suppl:81-90
pubmed: 15534815
Clin Pharmacol Ther. 2014 Nov;96(5):549-58
pubmed: 25054430
J Pharmacol Exp Ther. 2005 Jan;312(1):1-11
pubmed: 15306635
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:7330-3
pubmed: 24111438
J Clin Invest. 2005 Aug;115(8):2025-32
pubmed: 16075043
J Electrocardiol. 2011 May-Jun;44(3):320-5
pubmed: 21163494
Circulation. 1998 Jun 23;97(24):2420-5
pubmed: 9641694
Pediatrics. 2001 Jul;108(1):8-12
pubmed: 11433047
Acta Cardiol. 2015 Apr;70(2):211-6
pubmed: 26148382
Vojnosanit Pregl. 2015 Feb;72(2):192-5
pubmed: 25831915
J Am Heart Assoc. 2015 Apr 13;4(4):
pubmed: 25870186
J Am Coll Cardiol. 2008 Jun 17;51(24):2291-300
pubmed: 18549912
Stat Med. 2005 May 30;24(10):1579-607
pubmed: 15685718
Ther Adv Drug Saf. 2012 Oct;3(5):241-53
pubmed: 25083239
Med Biol Eng Comput. 2005 May;43(3):379-85
pubmed: 16035227
Br J Clin Pharmacol. 2002 Aug;54(2):188-202
pubmed: 12207642
Stat Med. 2007 Feb 10;26(3):596-619
pubmed: 16538699
Br J Sports Med. 2013 Jan;47(1):28-33
pubmed: 23193325
Crit Care Nurse. 2012 Oct;32(5):32-41
pubmed: 23027789
Heart. 2003 Nov;89(11):1363-72
pubmed: 14594906
Acad Emerg Med. 2015 Oct;22(10):1139-44
pubmed: 26375169
Cell Calcium. 2004 Jun;35(6):543-7
pubmed: 15110144
Am Heart J. 2002 Nov;144(5):769-81
pubmed: 12422144
J Am Coll Cardiol. 2017 Aug 29;70(9):1183-1192
pubmed: 28838369
Curr Pharm Des. 2006;12(18):2271-83
pubmed: 16787254
J Am Coll Cardiol. 2010 Mar 2;55(9):934-47
pubmed: 20185054
Biosensors (Basel). 2019 Jan 21;9(1):
pubmed: 30669678
Drug Saf. 2007;30(6):533-40
pubmed: 17536879
Vision Res. 1993 Sep;33(14):1937-58
pubmed: 8249312
Am J Med. 2002 Jan;112(1):58-66
pubmed: 11812408
Acad Radiol. 2008 May;15(5):647-61
pubmed: 18423323
Res Dev Disabil. 2011 Nov-Dec;32(6):2889-93
pubmed: 21696918
Curr Cardiol Rev. 2014 Aug;10(3):287-94
pubmed: 24827793
J Am Med Inform Assoc. 2019 May 1;26(5):404-411
pubmed: 30848818
J Med Imaging (Bellingham). 2018 Oct;5(4):045503
pubmed: 30525062
Fed Regist. 2005 Oct 20;70(202):61134-5
pubmed: 16237860
Heart Rhythm. 2005 Jun;2(6):569-74
pubmed: 15922261
Front Psychol. 2014 Oct 01;5:1099
pubmed: 25324806
Am Heart J. 2018 Jun;200:1-10
pubmed: 29898835
Dev Sci. 2009 Mar;12(2):326-38
pubmed: 19143805
Invest Radiol. 1992 Sep;27(9):723-31
pubmed: 1399456
J Cardiovasc Electrophysiol. 2006 Mar;17(3):333-6
pubmed: 16643414
Circulation. 1991 Sep;84(3):1136-44
pubmed: 1884444
Heart Rhythm. 2015 Nov;12(11):2263-71
pubmed: 26142298
Am J Health Syst Pharm. 2018 Mar 1;75(5):276-282
pubmed: 29317399
Ann Pediatr Cardiol. 2008 Jan;1(1):18-26
pubmed: 20300233
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):164-72
pubmed: 20728704
Cardiol Clin. 2006 Aug;24(3):491-504, x
pubmed: 16939838

Auteurs

Alaa Alahmadi (A)

Department of Computer Science, The University of Manchester, Manchester, United Kingdom.

Alan Davies (A)

Division of Informatics, Imaging and Data Sciences, School of Health Sciences, The University of Manchester, Manchester, United Kingdom.

Markel Vigo (M)

Department of Computer Science, The University of Manchester, Manchester, United Kingdom.

Caroline Jay (C)

Department of Computer Science, The University of Manchester, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH